packageIxazomib

ixazomib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Ixazomib is a proteasome inhibitor used to treat multiple myeloma and amyloidosis. It is an approved anticancer medicine authorised in the European Union for multiple myeloma.

Summary written by glm-5.3-flash from Wikidata Q20948663 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:ixazomib
ATC codes:L01XG03
DrugBank:DB09570
PubChem CID:25183872
ChEBI:90942
Wikidata:Q20948663
formula:C14H19BCl2N2O4
molar mass:361.026 g/mol (PubChem CID 25183872)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown